Search Results - "Shingaki, Naoki"

Prognostic impact of surgery and radiofrequency ablation on single nodular HCC ⩽5 cm: Cohort study based on serum HCC markers by Ueno, Masaki, Hayami, Shinya, Shigekawa, Yoshinobu, Kawai, Manabu, Hirono, Seiko, Okada, Ken-ichi, Tamai, Hideyuki, Shingaki, Naoki, Mori, Yoshiyuki, Ichinose, Masao, Yamaue, Hiroki

“…Graphical abstract…”
Get full text

Serum pepsinogen levels can quantify the risk of development of metachronous gastric cancer after endoscopic resection by Iguchi, Mikitaka, Kato, Jun, Yoshida, Takeichi, Yamamoto, Yasuhide, Nakachi, Kenichiro, Fukatsu, Kazuhiro, Mori, Yoshiyuki, Maeda, Yoshimasa, Moribata, Kosaku, Shingaki, Naoki, Niwa, Toru, Deguchi, Hisanobu, Inoue, Izumi, Maekita, Takao, Tamai, Hideyuki, Ichinose, Masao

“…We have previously reported that serum pepsinogen (PG) can quantify the level of gastric mucosal atrophy, and that H. pylori eradication reduces cancer…”
Get full text

Clinical features and risk factors of extrahepatic seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma by Shirai, Kiyokazu, Tamai, Hideyuki, Shingaki, Naoki, Mori, Yoshiyuki, Moribata, Kosaku, Enomoto, Shotaro, Deguchi, Hisanobu, Ueda, Kazuki, Maekita, Takao, Inoue, Izumi, Iguchi, Mikitaka, Yanaoka, Kimihiko, Oka, Masashi, Ichinose, Masao

“…Aim:  To clarify the clinical features of and risk factors for extrahepatic seeding, a major complication following radiofrequency ablation (RFA) for…”
Get full text

Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with small hepatocellular carcinoma treated by radiofrequency ablation by Ida, Yoshiyuki, Tamai, Hideyuki, Shingaki, Naoki, Shimizu, Ryo, Maeshima, Shuya, Maekita, Takao, Iguchi, Mikitaka, Terada, Masaki, Kitano, Masayuki

“…Background .sup.18F-fluorodeoxyglucose (.sup.18F-FDG) uptake in hepatocellular carcinoma (HCC) is significantly associated with early recurrence and survival…”
Get full text

Feeding artery ablation before radiofrequency ablation for hepatocellular carcinoma may reduce critical recurrence by Shimizu, Ryo, Tamai, Hideyuki, Ida, Yoshiyuki, Maeshima, Shuya, Shingaki, Naoki, Maekita, Takao, Iguchi, Mikitaka, Kitano, Masayuki

“…Background and Aim Percutaneous radiofrequency ablation (RFA) is a minimally invasive and curative local treatment for hepatocellular carcinoma (HCC). However,…”
Get full text

Endoscopic features associated with development of metachronous gastric cancer in patients who underwent endoscopic resection followed by Helicobacter pylori eradication by Moribata, Kosaku, Kato, Jun, Iguchi, Mikitaka, Nakachi, Kenichiro, Maeda, Yoshimasa, Shingaki, Naoki, Niwa, Toru, Deguchi, Hisanobu, Inoue, Izumi, Maekita, Takao, Tamai, Hideyuki, Ichinose, Masao

“…Background and Aim The preventive effect of Helicobacter pylori (HP) eradication on metachronous gastric cancer development after endoscopic resection remains…”
Get full text

Hypointense hepatocellular carcinomas on apparent diffusion coefficient mapping: Pathological features and metastatic recurrence after hepatectomy by Mori, Yoshiyuki, Tamai, Hideyuki, Shingaki, Naoki, Hayami, Shinya, Ueno, Masaki, Maeda, Yoshimasa, Moribata, Kosaku, Deguchi, Hisanobu, Niwa, Toru, Inoue, Izumi, Maekita, Takao, Iguchi, Mikitaka, Kato, Jun, Terada, Masaki, Yamaue, Hiroki, Ichinose, Masao

“…Aim The present study aimed to evaluate pathological features of hepatocellular carcinomas (HCC) appearing hypointense on the apparent diffusion coefficient…”
Get full text

Signal intensity of small hepatocellular carcinoma on apparent diffusion coefficient mapping and outcome after radiofrequency ablation by Mori, Yoshiyuki, Tamai, Hideyuki, Shingaki, Naoki, Moribata, Kosaku, Deguchi, Hisanobu, Ueda, Kazuki, Inoue, Izumi, Maekita, Takao, Iguchi, Mikitaka, Kato, Jun, Terada, Masaki, Ichinose, Masao

“…Aim It has been reported that the apparent diffusion coefficient (ADC) value of hepatocellular carcinomas (HCC) on diffusion‐weighted magnetic resonance…”
Get full text

Combination with portosystemic shunt occlusion and antiviral therapy improves prognosis of decompensated cirrhosis by Tamai, Hideyuki, Minamiguchi, Hiroki, Ida, Yoshiyuki, Shingaki, Naoki, Muroki, Tokuro, Maeshima, Shuya, Shimizu, Ryo, Okamura, Junpei, Koyama, Takao, Nakao, Taisei, Sonomura, Tetsuo

“…Background and Aim Portosystemic shunt occlusion using endovascular treatment can transiently improve liver function in patients with decompensated cirrhosis…”
Get full text

The Real-World Safety and Efficacy of Daclatasvir and Asunaprevir for Elderly Patients by Taki, Shinya, Tamai, Hideyuki, Ida, Yoshiyuki, Shingaki, Naoki, Kawashima, Akira, Shimizu, Ryo, Moribata, Kosaku, Maekita, Takao, Iguchi, Mikitaka, Kato, Jun, Nakao, Taisei, Kitano, Masayuki

“…Although daclatasvir with asunaprevir was approved in Japan for interferon ineligible or intolerant patients, patients aged ≥75 years were excluded in the…”
Get full text

Argon plasma coagulation is effective for prevention of recurrent esophageal varices after endoscopic injection sclerotherapy: Single-center case-control study by Deguchi, Hisanobu, Kato, Jun, Maeda, Yoshimasa, Moribata, Kosaku, Shingaki, Naoki, Niwa, Toru, Inoue, Izumi, Maekita, Takao, Iguchi, Mikitaka, Tamai, Hideyuki, Ichinose, Masao

“…Background and Aim Esophageal varices are usually treated with endoscopic injection sclerotherapy (EIS) or endoscopic band ligation (EBL). However, frequent…”
Get full text

Prediction of poorly differentiated hepatocellular carcinoma using contrast computed tomography by Nakachi, Kenichiro, Tamai, Hideyuki, Mori, Yoshiyuki, Shingaki, Naoki, Moribata, Kosaku, Deguchi, Hisanobu, Ueda, Kazuki, Inoue, Izumi, Maekita, Takao, Iguchi, Mikitaka, Kato, Jun, Ichinose, Masao

“…Percutaneous radiofrequency ablation (RFA) is a well-established local treatment for small hepatocellular carcinoma (HCC). However, poor differentiation is a…”
Get full text

Contrast-Enhanced Ultrasonography in the Diagnosis of Solid Renal Tumors by Tamai, Hideyuki, Takiguchi, Yoshie, Oka, Masashi, Shingaki, Naoki, Enomoto, Shotaro, Shiraki, Tatsuya, Furuta, Machi, Inoue, Izumi, Iguchi, Mikitaka, Yanaoka, Kimihiko, Arii, Kenji, Shimizu, Yasuhito, Nakata, Hiroya, Shinka, Toshiaki, Sanke, Tokio, Ichinose, Masao

“…Objective The purpose of this study was to evaluate the usefulness of contrast‐enhanced ultrasonography (CEUS) in the diagnosis of solid renal tumors. Methods…”
Get full text

Simeprevir-Based Triple Therapy with Reduced Doses of Pegylated Interferon α-2a Plus Ribavirin for Interferon Ineligible Patients with Genotype 1b Hepatitis C Virus by Tamai, Hideyuki, Ida, Yoshiyuki, Kawashima, Akira, Shingaki, Naoki, Shimizu, Ryo, Moribata, Kosaku, Nasu, Tetsushi, Maekita, Takao, Iguchi, Mikitaka, Kato, Jun, Nakao, Taisei, Kitano, Masayuki

“…The present study aimed to evaluate the safety and efficacy of simeprevir-based triple therapy with reduced doses of pegylated interferon (PEG-IFN) and…”
Get full text

Low-dose pegylated interferon-alpha-2a monotherapy in elderly and/or cirrhotic patients infected with hepatitis C virus genotype-2 or genotype-1 low level infection by Tamai, Hideyuki, Moribata, Kosaku, Mori, Yoshiyuki, Shingaki, Naoki, Deguchi, Hisanobu, Ueda, Kazuki, Inoue, Izumi, Maekita, Takao, Iguchi, Mikitaka, Kato, Jun, Ichinose, Masao

“…Aim Elderly and/or cirrhotic patients with hepatitis C virus (HCV) are at high risk of adverse effects during interferon therapy. The aim of the present study…”
Get full text

Prediction of efficacy to pegylated interferon-α-2b plus ribavirin in patients with genotype 2 hepatitis C virus using viral response within 2 weeks by Wada, Yuki, Tamai, Hideyuki, Uno, Akiko, Kawashima, Akira, Shingaki, Naoki, Mori, Yoshiyuki, Moribata, Kosaku, Miyata, Kaori, Higashi, Katsuhiko, Deguchi, Hisanobu, Ueda, Kazuki, Inoue, Izumi, Maekita, Takao, Iguchi, Mikitaka, Kato, Jun, Ichinose, Masao

“…Aim Rapid virological response (RVR), defined as serum hepatitis C virus (HCV) RNA negativity at 4 weeks, is the most useful predictor of sustained virological…”
Get full text

Prediction of sustained response to low-dose pegylated interferon alpha-2b plus ribavirin in patients with genotype 1b and high hepatitis C virus level using viral reduction within 2 weeks after therapy initiation by Tamai, Hideyuki, Shingaki, Naoki, Shiraki, Tatsuya, Tukuda, Hiroshi, Mori, Yoshiyuki, Moribata, Kosaku, Enomoto, Shotaro, Deguchi, Hisanobu, Ueda, Kazuki, Inoue, Izumi, Maekita, Takao, Iguchi, Mikitaka, Yanaoka, Kimihiko, Oka, Masashi, Ichinose, Masao

“…Aim:  Continuation of pegylated interferon (PEG‐IFN) plus ribavirin at the recommended dose is difficult in elderly patients and/or patients with cytopenia or…”
Get full text

Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus by Tamai, Hideyuki, Shingaki, Naoki, Mori, Yoshiyuki, Moribata, Kosaku, Kawashima, Akira, Maeda, Yoshimasa, Niwa, Toru, Deguchi, Hisanobu, Inoue, Izumi, Maekita, Takao, Iguchi, Mikitaka, Kato, Jun, Ichinose, Masao

“…This study aimed to predict sustained viral response (SVR) to low-dose pegylated interferon (PEG-IFN) plus ribavirin of elderly and/or cirrhotic patients with…”
Get full text

Diffuse intrahepatic recurrence after percutaneous radiofrequency ablation for solitary and small hepatocellular carcinoma by Mori, Yoshiyuki, Tamai, Hideyuki, Shingaki, Naoki, Moribata, Kosaku, Shiraki, Tatsuya, Deguchi, Hisanobu, Ueda, Kazuki, Enomoto, Shotaro, Magari, Hiroto, Inoue, Izumi, Maekita, Takao, Iguchi, Mikitaka, Yanaoka, Kimihiko, Oka, Masashi, Ichinose, Masao

“…Two patients developed segmental, diffuse intrahepatic recurrence after percutaneous radiofrequency ablation (RFA) to treat a primary, solitary, and small…”
Get full text

Assessment of malignant potential of small hypervascular hepatocellular carcinoma using B-mode ultrasonography by Moribata, Kosaku, Tamai, Hideyuki, Shingaki, Naoki, Mori, Yoshiyuki, Enomoto, Shotaro, Shiraki, Tatsuya, Deguchi, Hisanobu, Ueda, Kazuki, Inoue, Izumi, Maekita, Takao, Iguchi, Mikitaka, Yanaoka, Kimihiko, Oka, Masashi, Ichinose, Masao

“…Aim:  Evaluation of malignant potential is important to determine the treatment strategy for small hepatocellular carcinoma (HCC). The aim of the present study…”
Get full text